A low prevalence of Parkinson’s disease (PD) has been reported in the Sub-Saharan Africa (SSA) region. The genetic causes and clinical features of PD in this region have been poorly described. Very few reports have examined the availability and access to evidence-based quality care for people living with PD in this region. We reviewed all publications focusing on idiopathic PD from SSA published up to May 2016 and observed a prevalence of PD ranging from 7/100,000 in Ethiopia to 67/100,000 in Nigeria. The most recent community-based study reported a mean age at onset of 69.4 years. The infrequent occurrence of mutations in established PD genes was also observed in the region. Treatments were non-existent or at best irregular. Additionally, there is a lack of well-trained medical personnel and multidisciplinary teams in most countries in this region. Drugs for treating PD are either not available or unaffordable. Large-scale genetic and epidemiological studies are therefore needed in SSA to provide further insights into the roles of genetics and other etiological
factors in the pathogenesis of PD. The quality of care also requires urgent improvement to meet the basic level of care required by PD patients.
Citations
Citations to this article as recorded by
Addressing Neurological Inequities in Developing Countries: Challenges and Strategic Solutions Amit Kandel Sarvodaya International Journal of Medicine.2025; 1(1): 1. CrossRef
Rethinking ‘rare’ PINK1 Parkinson's disease: A meta-analysis of geographical prevalence, phenotypic diversity, and α-synuclein pathology Eden Paige Yin, Birger Victor Dieriks Journal of Parkinson’s Disease.2025;[Epub] CrossRef
Delivery of Allied Health Therapies to People with Parkinson’s Disease in Africa Roberto Cilia, Marieke C.J. Dekker, Esther Cubo, Mary W. Agoriwo Journal of Parkinson’s Disease.2024; 14(s1): S227. CrossRef
The Role of Diet in Parkinson’s Disease Kira N. Tosefsky, Julie Zhu, Yolanda N. Wang, Joyce S.T. Lam, Amanda Cammalleri, Silke Appel-Cresswell Journal of Parkinson’s Disease.2024; 14(s1): S21. CrossRef
Advancing genetic testing for neurological disorders in Tanzania: importance, challenges, and strategies for implementation Mohamed Zahir Alimohamed, Angela Augustine Siima, Mohamed Manji Frontiers in Neuroscience.2024;[Epub] CrossRef
Epidemiology of Parkinson’s Disease: An Update Juan R Deliz, Caroline M. Tanner, Paulina Gonzalez-Latapi Current Neurology and Neuroscience Reports.2024; 24(6): 163. CrossRef
Spondias mombin flavonoids showed super-binder ability with downstream molecular targets of Parkinson's disease: A structural study John A. Olanrewaju, Leviticus O. Arietarhire, Oladimeji E. Soremekun, Ezekiel A. Olugbogi, Toluwanimi O. Afolabi, Precious O. Aribisala, Pelumi E. Alege, Abayomi O. Sodipo, Babatunji E. Oyinloye, Olaposi I. Omotuyi Informatics in Medicine Unlocked.2024; 49: 101543. CrossRef
Breaking barriers in Parkinson’s care: the multidisciplinary team approach Zvezdan Pirtošek Journal of Neural Transmission.2024; 131(11): 1349. CrossRef
Structure and process of Parkinson's disease rehabilitation in the southern sector of Ghana: A cross‐sectional survey Mary W. Agoriwo, Conran Joseph, Erika Franzén, Marianne Unger Journal of Evaluation in Clinical Practice.2024;[Epub] CrossRef
Phytoconstituents of Datura metel extract improved motor coordination in haloperidol-induced cataleptic mice: Dual-target molecular docking and behavioural studies Bilqis Abiola Lawal, Yusuf Oloruntoyin Ayipo, Abisola Oyindamola Adekunle, Mohammed Otuofu Amali, Umar Muhammad Badeggi, Waleed A. Alananzeh, Mohd Nizam Mordi Journal of Ethnopharmacology.2023; 300: 115753. CrossRef
Particularités de la Maladie de Parkinson de la personne âgée : expérience du service de gériatrie de Fann à Dakar (Sénégal) A. Sall, M. Ba, R. Djajheté, D. Ba, S. Zaki, M. Coumé NPG Neurologie - Psychiatrie - Gériatrie.2023; 23(134): 85. CrossRef
The Gaps and Prospects of Movement Disorders Education and Research in Africa: A Continental Survey Eman Hamid, Kigocha Okengo, Biniyam A. Ayele, Daniel Gams Massi, Samia Ben Sassi, Houyam Tibar, Sarah Misbah El‐Sadig, Soulaimane Mahoui, Julien Razafimahefa, Ange Eric Kouame‐Assouan, Djibrilla Ben‐Adji, Lengane Y.T. Modeste, Muhyadin Hassan Mohamed, Nes Movement Disorders.2023; 38(2): 178. CrossRef
Transforming Parkinson's Care in Africa (TraPCAf): protocol for a multimethodology National Institute for Health and Care Research Global Health Research Group project R. Walker, N. Fothergill-Misbah, S. Kariuki, O. Ojo, R. Cilia, M. C. J. Dekker, O. Agabi, A. Akpalu, F. Amod, M. Breckons, M. Cham, S. Del Din, C. Dotchin, S. Guggsa, J. Kwasa, D. Mushi, F. O. Nwaokorie, T. Park, L. Rochester, J. Rogathi, F. S. Sarfo, A. BMC Neurology.2023;[Epub] CrossRef
Exploring the levodopa-paradox of freezing of gait in dopaminergic medication-naïve Parkinson’s disease populations Jamie A. F. Jansen, Tamine T. C. Capato, Sirwan K. L. Darweesh, Egberto R. Barbosa, Rogier Donders, Bastiaan R. Bloem, Jorik Nonnekes npj Parkinson's Disease.2023;[Epub] CrossRef
The intestinal luminal sources of α-synuclein: a gastroenterologist perspective Aaron Lerner Nutrition Reviews.2022; 80(2): 282. CrossRef
Surveying Global Availability of Parkinson’s Disease Treatment Zhao H.K. Goh, Julia L.Y. Cheong, Connie Marras, Caroline M. Tanner, Meike Kasten, Amos D. Korczyn, Lana Chahine, Raymond Lo, Alastair J. Noyce Journal of Parkinson’s Disease.2022; 12(3): 1023. CrossRef
Current Status of Next-Generation Sequencing Approaches for Candidate Gene Discovery in Familial Parkinson´s Disease Nikita Simone Pillay, Owen A. Ross, Alan Christoffels, Soraya Bardien Frontiers in Genetics.2022;[Epub] CrossRef
Utility of 18F FDG-PET in Parkinsonism in an African population Ferzana Hassan Amod, Ahmed Iqbal Bhigjee, Nozipho Nyakale eNeurologicalSci.2022; 27: 100399. CrossRef
A Narrative Review of Specialist Parkinson’s Nurses: Evolution, Evidence and Expectation Emma Tenison, Alice James, Louise Ebenezer, Emily J. Henderson Geriatrics.2022; 7(2): 46. CrossRef
Treatment with bark extracts of Voacanga africana attenuates motor coordination deficit, depressive-like behavior and microglial reaction, in a mouse model of early Parkinson's disease Salimata Diagne Houndjo, Christophe Melon, Pascal Salin, Abdoulaye Samb, Fatou Bintou Sarr, Lydia Kerkerian-Le Goff, Sylviane Lortet Phytomedicine Plus.2022; 2(3): 100297. CrossRef
Polygenic risk prediction and SNCA haplotype analysis in a Latino Parkinson's disease cohort Douglas P. Loesch, Andrea R.V.R. Horimoto, Elif Irem Sarihan, Miguel Inca-Martinez, Emily Mason, Mario Cornejo-Olivas, Luis Torres, Pilar Mazzetti, Carlos Cosentino, Elison Sarapura-Castro, Andrea Rivera-Valdivia, Angel C. Medina, Elena Dieguez, Victor Ra Parkinsonism & Related Disorders.2022; 102: 7. CrossRef
The impact of COVID‐19 on patients with neurological disorders and their access to healthcare in Africa: A review of the literature Olivier Uwishema, Kristian Steen Frederiksen, Inês F. Silva Correia, Ashraf Mahmoud, Helen Onyeaka, Burhan Dost Brain and Behavior.2022;[Epub] CrossRef
Perspective: Low Risk of Parkinson's Disease in Quasi-Vegan Cultures May Reflect GCN2-Mediated Upregulation of Parkin Mark F McCarty, Aaron Lerner Advances in Nutrition.2021; 12(2): 355. CrossRef
A Rapid Motor Task-Based Screening Tool for Parkinsonism in Community-Based Studies Wendy W. Dlamini, Searles Nielsen, Mwiza Ushe, Gill Nelson, Brad A. Racette Frontiers in Neurology.2021;[Epub] CrossRef
Parkinson disease-associated cognitive impairment Dag Aarsland, Lucia Batzu, Glenda M. Halliday, Gert J. Geurtsen, Clive Ballard, K. Ray Chaudhuri, Daniel Weintraub Nature Reviews Disease Primers.2021;[Epub] CrossRef
Probing the Pre-diagnostic Phase of Parkinson's Disease in Population-Based Studies Lisanne J. Dommershuijsen, Agnita J. W. Boon, M. Kamran Ikram Frontiers in Neurology.2021;[Epub] CrossRef
Medicinal plants for anti-neurodegenerative diseases in West Africa Emmanuel Ayodeji Ayeni, Yuzhou Gong, Hao Yuan, Yikao Hu, Xiaolin Bai, Xun Liao Journal of Ethnopharmacology.2021; : 114468. CrossRef
Mapping the Diverse and Inclusive Future of Parkinson’s Disease Genetics and Its Widespread Impact Inas Elsayed, Alejandro Martinez-Carrasco, Mario Cornejo-Olivas, Sara Bandres-Ciga Genes.2021; 12(11): 1681. CrossRef
Parkinson’s disease – a review of pathogenesis, recent advances in management, and challenges of care in sub-Saharan Africa Akintomiwa I. Makanjuola, Funmilola T. Taiwo, Joseph O. Yaria, Rufus O. Akinyemi, Adesola Ogunniyi Journal of Global Medicine.2021; : e35. CrossRef
Genetics of Parkinson's disease: An introspection of its journey towards precision medicine Sara Bandres-Ciga, Monica Diez-Fairen, Jonggeol Jeff Kim, Andrew B. Singleton Neurobiology of Disease.2020; 137: 104782. CrossRef
Targeted next-generation sequencing identifies novel variants in candidate genes for Parkinson’s disease in Black South African and Nigerian patients Oluwafemi G. Oluwole, Helena Kuivaniemi, Shameemah Abrahams, William L. Haylett, Alvera A. Vorster, Carel J. van Heerden, Colin P. Kenyon, David L. Tabb, Michael B. Fawale, Taofiki A. Sunmonu, Abiodun Ajose, Matthew O. Olaogun, Anastasia C. Rossouw, Ludo BMC Medical Genetics.2020;[Epub] CrossRef
Translation, Validation, Diagnostic Accuracy, and Reliability of Screening Questionnaire for Parkinsonism in Three African Countries Ali Shalash, Njideka U. Okubadejo, Jacques Doumbe, Oluwadamilola O. Ojo, Eman Hamid, Callixte Kuate, Sara Calvo, Asmaa Helmi, Osigwe P. Agabi, Mohamed Essam, Laura Aguado, Hanan Elrassas, Tamer Roushdy, Caroline M. Tanner, Esther Cubo Journal of Parkinson's Disease.2020; 10(3): 1113. CrossRef
Parkinson's Disease Research on the African Continent: Obstacles and Opportunities Marieke C. J. Dekker, Toumany Coulibaly, Soraya Bardien, Owen A. Ross, Jonathan Carr, Morenikeji Komolafe Frontiers in Neurology.2020;[Epub] CrossRef
Chitosan-Coated Hydroxypropylmethyl Cellulose Microparticles of Levodopa (and Carbidopa): In Vitro and Rat Model Kinetic Characteristics Benedicta Obenewaa Dankyi, Seth Kwabena Amponsah, Grace Lovia Allotey-Babington, Ismaila Adams, Nana Aboadwe Goode, Henry Nettey Current Therapeutic Research.2020; 93: 100612. CrossRef
Parkinson's disease in Nigeria: A review of published studies and recommendations for future research Oluwafemi G. Oluwole, Helena Kuivaniemi, Jonathan A. Carr, Owen A. Ross, Matthew O.B. Olaogun, Soraya Bardien, Morenikeji A. Komolafe Parkinsonism & Related Disorders.2019; 62: 36. CrossRef
Clinical series of Parkinson's disease in KwaZulu-Natal, South Africa: Retrospective chart review Ferzana Hassan Amod, Ahmed Iqbal Bhigjee Journal of the Neurological Sciences.2019; 401: 62. CrossRef
Frequency of the LRRK2 G2019S mutation in South African patients with Parkinson’s disease Nicola du Toit, Riaan van Coller, David G. Anderson, Jonathan Carr, Soraya Bardien neurogenetics.2019; 20(4): 215. CrossRef
Ethnic Variation in the Manifestation of Parkinson’s Disease: A Narrative Review Aaron Ben-Joseph, Charles R. Marshall, Andrew J. Lees, Alastair J. Noyce Journal of Parkinson’s Disease.2019; 10(1): 31. CrossRef
Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease Njideka U. Okubadejo, Mie Rizig, Oluwadamilola O. Ojo, Hallgeir Jonvik, Olajumoke Oshinaike, Emmeline Brown, Henry Houlden, Hiroyoshi Ariga PLOS ONE.2018; 13(12): e0207984. CrossRef
Motor Symptoms of Parkinson’s Disease – A Review Literature Hilda Aboagyewaa Agyekum Neurophysiology and Rehabilitation.2018; : 38. CrossRef